美国国会山一个由81名议员组成的跨党派团体在关于GLP-1行动的信函上签名。他们施压美国食品药品管理局（FDA），要求对混合物与假冒GLP-1药物采取行动。平价减肥药供应商Hims & Hers Health Inc.（HIMS）股价短线跳水，日内整体转而下跌2.56%。

Group 1 - A bipartisan group of 81 lawmakers is pressuring the FDA to take action against counterfeit GLP-1 drugs and mixtures [1][2] - Hims & Hers Health Inc. (HIMS), a provider of affordable weight loss medications, experienced a short-term stock drop, declining by 2.56% during the day [3]